Table 4.
The causes of death of insulin vs glimepiride groups in patients with background metformin therapy.
Metformin | Insulin vs glimepiride | |||
Glimepiride n (%) | Insulin n (%) | Adjusted HR (95% CI) | P value | |
Causes of CV death | 2 (0.20) | 10 (0.97) | 7.95 (1.65–38.3) | .01 |
Ischemic heart disease | 0 | 1 | ||
Sudden cardiac death | 0 | 3 | ||
Heart failure | 1 | 1 | ||
Stroke | 1 | 2 | ||
Cardiovascular procedure | ||||
Cardiovascular hemorrhage | 0 | 3 | ||
Other cardiovascular causes | ||||
Non-cardiovascular causes of death | 13 (1.27) | 142 (13.83) | 14.9 (8.4–26.3) | <.001 |
Cancers | 3 | 52 | ||
others | 10 | 90 | ||
Undetermined | 1 (0.10) | 14 (1.36) | 23.9 (3.1–184) | .002 |